London Drugs luxury airline subsidiary puts five new Learjets into service

London Air Services, the private-jet air travel division of Richmond-based London Drugs, has added five new Bombardier Learjet 75 jets to its service.

London Air Services, the private-jet air travel division of Richmond-based London Drugs, has added five new Bombardier Learjet 75 jets to its service.

The company spent $67 million on the new jets, which are now in service, the company confirmed.

That brings the company's stable of jets to eight. It also has three AW139 helicopters.

Larger than the existing fleet of Learjet 45s, the Learjet 75 can fly across North America without refuelling and can accommodate up to eight business travellers.

"With new cabin technology, Wi-Fi capabilities, energy-saving LED lighting and up to 4% in improved fuel efficiency, the new Learjet 75 is an excellent complement to our existing fleet," said London Air Services CEO Wynne Powell.

"Bombardier continues to build best-in-class business aircraft, and the new additions will allow London Air Services to provide optimal service to our business clients."

Powell launched the new air service, which caters to business travellers, with a single jet in 1999 out of frustration with other private-jet operators. With drugstores spread across Canada, Powell is a frequent flyer and decided it would be more cost effective to buy his own jet and make it available to other business travellers.

nbennett@biv.com

@nbennett_biv